Furthermore, NSCLC tumors often exhibit mechanisms of immune evasion, such as the upregulation of immune checkpoint molecules (PD-L1), the recruitment of regulatory T cells, and the exclusion of cytotoxic T cells, which enable unchecked proliferation and resistance to immune surveillance [30]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.